-transparent.png){kind=logo}
GR138676, a conformationally constrained analogue of neurokinin B, is a novel, potent NK3 receptor antagonist. GR138676 was a competitive antagonist of neurokinin B-dependent arachidonic acid mobilization from prelabelled Chinese hamster ovary cells stably transfected with a human NK3 receptor gene (pKB 8.3) and of contractions induced by senktide in rat portal vein (pKB 8.2). However, GR138676 was also a competitive antagonist of the increase in intracellular calcium evoked by the selective NK1 agonist, GR73632, in the human astrocytoma U373MG cell-line (pKB 8.3). GR138676 had little activity at NK2 receptors, inhibiting binding of the NK2 antagonist radioligand [3H]-GR100679 to Chinese hamster ovary cells transfected with the human ileum NK2 receptor with a pKi of 6.0. In summary, despite its activity at NK1 receptors, GR138676 will be a useful tool for characterizing NK3 receptors as well as defining the physiological and pathophysiological function of this receptor subtype.
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
January 1995,
European journal of pharmacology,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
January 1995,
Life sciences,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
May 2002,
Canadian journal of physiology and pharmacology,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
February 2011,
British journal of pharmacology,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
February 1994,
Biochemical and biophysical research communications,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
October 1991,
Neuropeptides,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
October 1991,
European journal of pharmacology,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
January 1997,
European journal of pharmacology,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
January 1994,
Brain research bulletin,
J M Stables, and
I J Beresford, and
S Arkinstall, and
S J Ireland, and
D M Walsh, and
P W Seale, and
P Ward, and
R M Hagan
December 1994,
The Journal of pharmacology and experimental therapeutics,
